Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Frontiers in Molecular Biosciences
|
July 6, 2017
AAA-ATPases in Protein Degradation
Ravikiran S Yedidi, Petra Wendler, Cordula Enenkel
Critical Reviews in Biochemistry and Molecular Biology
|
September 29, 2016
Proteasome dynamics between proliferation and quiescence stages of Saccharomyces cerevisiae
Ravikiran S Yedidi, Amatullah K Fatehi, Cordula Enenkel
Journal of Medicinal Chemistry
|
May 5, 2010
Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents
Deepak Gupta, Ravikiran S Yedidi, Sheeba Varghese, et al.
Journal of Molecular Graphics & Modelling
|
December 3, 2013
P1 and P1' para-fluoro phenyl groups show enhanced binding and favorable predicted pharmacological properties: structure-based virtual screening of extended lopinavir analogs against multi-drug resistant HIV-1 protease
Ravikiran S Yedidi, Zhigang Liu, Iulia A Kovari, et al.
Biochemical and Biophysical Research Communications
|
August 31, 2024
Leveraging the potential of bacterial lateral gene transfer in boosting the efficacy of an edible probiotic prototype yogurt vaccine for COVID-19
Madhuri Vissapragada, Santhinissi Addala, Madhumita Aggunna, et al.
Biochimica Et Biophysica Acta. General Subjects
|
November 21, 2025
Receptor binding domain of SARS CoV2 spike protein exhibits in vitro liquid-liquid phase separation due to structural disorderedness that may challenge the vaccine-generated antibody binding
Manikanta Sodasani, Abhinav V K S Grandhi, Niharikha Mukala, et al.
Journal of Molecular Graphics & Modelling
|
August 10, 2014
A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF
Ravikiran S Yedidi, Gheorghe Proteasa, Philip D Martin, et al.
Antimicrobial Agents and Chemotherapy
|
January 3, 2022
Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors <i>In Vitro</i>
Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez, et al.
Antimicrobial Agents and Chemotherapy
|
February 2, 2011
Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants
Kazuhiko Ide, Manabu Aoki, Masayuki Amano, et al.
Biochemical and Biophysical Research Communications
|
December 25, 2012
Conserved hydrogen bonds and water molecules in MDR HIV-1 protease substrate complexes
Zhigang Liu, Yong Wang, Ravikiran S Yedidi, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Frontiers in Molecular Biosciences
|
July 6, 2017
AAA-ATPases in Protein Degradation
Ravikiran S Yedidi, Petra Wendler, Cordula Enenkel
Critical Reviews in Biochemistry and Molecular Biology
|
September 29, 2016
Proteasome dynamics between proliferation and quiescence stages of Saccharomyces cerevisiae
Ravikiran S Yedidi, Amatullah K Fatehi, Cordula Enenkel
Journal of Medicinal Chemistry
|
May 5, 2010
Mechanism-based inhibitors of the aspartyl protease plasmepsin II as potential antimalarial agents
Deepak Gupta, Ravikiran S Yedidi, Sheeba Varghese, et al.
Journal of Molecular Graphics & Modelling
|
December 3, 2013
P1 and P1' para-fluoro phenyl groups show enhanced binding and favorable predicted pharmacological properties: structure-based virtual screening of extended lopinavir analogs against multi-drug resistant HIV-1 protease
Ravikiran S Yedidi, Zhigang Liu, Iulia A Kovari, et al.
Biochemical and Biophysical Research Communications
|
August 31, 2024
Leveraging the potential of bacterial lateral gene transfer in boosting the efficacy of an edible probiotic prototype yogurt vaccine for COVID-19
Madhuri Vissapragada, Santhinissi Addala, Madhumita Aggunna, et al.
Biochimica Et Biophysica Acta. General Subjects
|
November 21, 2025
Receptor binding domain of SARS CoV2 spike protein exhibits in vitro liquid-liquid phase separation due to structural disorderedness that may challenge the vaccine-generated antibody binding
Manikanta Sodasani, Abhinav V K S Grandhi, Niharikha Mukala, et al.
Journal of Molecular Graphics & Modelling
|
August 10, 2014
A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF
Ravikiran S Yedidi, Gheorghe Proteasa, Philip D Martin, et al.
Antimicrobial Agents and Chemotherapy
|
January 3, 2022
Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors <i>In Vitro</i>
Masayuki Amano, Ravikiran S Yedidi, Pedro Miguel Salcedo-Gómez, et al.
Antimicrobial Agents and Chemotherapy
|
February 2, 2011
Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants
Kazuhiko Ide, Manabu Aoki, Masayuki Amano, et al.
Biochemical and Biophysical Research Communications
|
December 25, 2012
Conserved hydrogen bonds and water molecules in MDR HIV-1 protease substrate complexes
Zhigang Liu, Yong Wang, Ravikiran S Yedidi, et al.
Page
of 3